CCAAT/enhancer Binding Protein (C/EBP), delta (CEBPD) (Middle Region) Peptide
CEBPD
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all CEBPD products
- CEBPD (CCAAT/enhancer Binding Protein (C/EBP), delta (CEBPD))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- QTPAPGPARE KSAGKRGPDR GSPEYRQRRE RNNIAVRKSR DKAKRRNQEM
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-CEBPD Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- CEBPD (CCAAT/enhancer Binding Protein (C/EBP), delta (CEBPD))
- Background
-
The protein encoded by this intronless gene is a bZIP transcription factor which can bind as a homodimer to certain DNA regulatory regions. It can also form heterodimers with the related protein CEBP-alpha. The encoded protein is important in the regulation of genes involved in immune and inflammatory responses, and may be involved in the regulation of genes associated with activation and/or differentiation of macrophages. The cytogenetic location of this locus has been reported as both 8p11 and 8q11.
Alias Symbols: CELF, CRP3, C/EBP-delta, NF-IL6-beta
Protein Size: 269 - Gene ID
- 1052
- NCBI Accession
- NM_005195, NP_005186
- UniProt
- P49716
-
You are here:
